Trials

official impact factor 2.08

Open Access Highly Access Email this article to a friend

Validation of Heart Failure Events in the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) Participants Assigned to Doxazosin and Chlorthalidone

Linda B Piller*, Barry R Davis, Jeffrey A Cutler, William C Cushman, Jackson T Wright, Jeff D Williamson, Frans HH Leenen, Paula T Einhorn, Otelio S Randall, John S Golden, L Julian Haywood and the ALLHAT Collaborative Research Group

Current Controlled Trials in Cardiovascular Medicine 2002, 3:10 doi:10.1186/1468-6708-3-10

Fields marked * are required


Multiple email addresses should be separated with commas or semicolons.